Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance.

Urology
K I WishnowA C von Eschenbach

Abstract

We examined the records of 82 patients with clinical Stage I nonseminomatous germ cell tumors of the testis who, after radical orchiectomy, were treated by surveillance at M.D. Anderson Cancer Center between October, 1981, and March, 1987. Our purpose was to determine whether or not patients with a low risk of relapse can be identified at the time of the initial staging evaluation. In 30 of 82 patients (Group 1), embryonal carcinoma constituted less than 80 percent of the tumor, no vessel invasion was present, and the preorchiectomy serum AFP level was less than 80 ng/dL. No relapses occurred in this group. Fifty-two patients (Group 2) had more than 80 percent embryonal carcinoma or vessel invasion or a serum AFP level higher than 80 ng/dL. Relapse occurred in 24 (46%) of these patients. The difference in the rate of relapse between patients in Group 1 and Group 2 was statistically significant (P less than 0.00001). A separate analysis of teratoma as a predictor of nonrelapse showed that the orchiectomy specimens of 30 of the 82 patients contained more than 50 percent teratoma. Only 1 relapse occurred among 25 patients with more than 50 percent teratoma and no vessel invasion. Our data show that there is a subgroup of patients ...Continue Reading

Citations

Jan 1, 1996·Journal of Cancer Research and Clinical Oncology·C BokemeyerL Kanz
Nov 20, 1998·International Urology and Nephrology·K SuzukiH Yamanaka
Jul 29, 2009·World Journal of Urology·Dirk H Westermann, Urs E Studer
Dec 17, 1998·International Journal of Urology : Official Journal of the Japanese Urological Association·K SuzukiY Ogata
Nov 15, 2003·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Ali GuermaziEmile Sarfati
Jun 11, 2010·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Eddy S Leman, Mark L Gonzalgo
Mar 31, 2012·Archives of Pathology & Laboratory Medicine·Huihui Ye, Thomas M Ulbright
Jun 30, 2012·Pathology·Daniel M Berney
Sep 5, 1998·The Urologic Clinics of North America·R C Dean, J W Moul
Feb 7, 2012·The American Journal of Pathology·Vivek VenkataramaniStefan Schweyer
Jul 24, 2007·Critical Reviews in Oncology/hematology·R J GrollM A S Jewett
Feb 1, 1990·Cancer·C J Logothetis
Oct 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yvonne VergouweJ Dik F Habbema
Sep 5, 1998·The Urologic Clinics of North America·J M Gatti, R A Stephenson
Sep 5, 1998·The Urologic Clinics of North America·D B Lashley, B A Lowe
Oct 1, 1995·The Journal of Urology·D A Swanson
Sep 28, 2000·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·UNKNOWN Association of Directors of Anatomical and Surgical Pathology
Jun 15, 1999·BJU International·J P Van Brussel, G H Mickisch
Apr 20, 2018·Japanese Journal of Clinical Oncology·Yasuo ShinodaUNKNOWN Cancer Registration Committee of the Japanese Urological Association

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.